Biopharma BD&L: the tsunami is upon us
Pharma’s business development and licensing (BD&L) teams are at the forefront of identifying new science to support their company’s future. As the biopharma industry navigates an increasingly complex marketplace, traditional approaches to identifying and evaluating potential drug candidates are showing signs of strain.
How can pharmaceutical companies improve pipeline analysis?
In the pharmaceutical industry, pipeline analysis plays a vital role in managing and optimizing the drug portfolio. The goal is to provide comprehensive insights into the lifecycle of drug candidates, from discovery through clinical trials to market launch.
